Omaxe shares fell 5% on Friday due to a Securities and Exchange Board of India (Sebi) ban. Sebi has barred Omaxe, its Chairman Rohtas Goel, MD Mohit Goel, and three others from the securities market for two years for misrepresenting financials. The stock hit its lower circuit limits on both NSE and BSE, declining 15% over three sessions. Sebi also imposed a Rs 47 lakh fine on 16 entities. Omaxe plans to review the order and consider an appeal. This regulatory action may affect investor confidence in the real estate sector.
